Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study()

BACKGROUND: The aim of this study was to evaluate the safety, tolerability, and efficacy of a brand-generic glatiramer acetate product in patients with relapsing-remitting multiple sclerosis over a 12-month period. A noninterventional cohort study was conducted on 185 patients. The patients had a co...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Curr Ther Res Clin Exp
Главные авторы: Abolfazli, Roya, Pournourmohammadi, Shirin, Shamshiri, Ahmadreza, Samadzadeh, Sara
Формат: Artigo
Язык:Inglês
Опубликовано: Elsevier 2018
Предметы:
Original Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6008499/
https://ncbi.nlm.nih.gov/pubmed/29928468
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.curtheres.2018.05.001
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы